Cargando…

Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification

SIMPLE SUMMARY: Endometrial cancer (EC) is the most common gynaecologic malignancy in developed countries. Most patients are sufficiently treated with removal of uterus, tubes and ovaries. It depends on the estimated risk of metastases at diagnosis if more extensive surgery (removal of lymph nodes,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kasius, Jenneke C., Pijnenborg, Johanna M. A., Lindemann, Kristina, Forsse, David, van Zwol, Judith, Kristensen, Gunnar B., Krakstad, Camilla, Werner, Henrica M. J., Amant, Frédéric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616052/ https://www.ncbi.nlm.nih.gov/pubmed/34831000 http://dx.doi.org/10.3390/cancers13225848

Ejemplares similares

FIGO staging of endometrial cancer: 2023
por: Berek, Jonathan S., et al.
Publicado: (2023)

Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients
por: Tangen, Ingvild L, et al.
Publicado: (2017)

Improved preoperative risk stratification with CA-125 in low-grade endometrial cancer: a multicenter prospective cohort study
por: Reijnen, Casper, et al.
Publicado: (2019)

Interobserver agreement and prognostic impact for MRI–based 2018 FIGO staging parameters in uterine cervical cancer
por: Wagner-Larsen, Kari S., et al.
Publicado: (2022)

Salvage Radiation for Pelvic Relapse after Surgically Treated Endometrial Cancer
por: Lindemann, Kristina, et al.
Publicado: (2021)

Preoperative pelvic MRI and 2-[(18)F]FDG PET/CT for lymph node staging and prognostication in endometrial cancer—time to revisit current imaging guidelines?
por: Fasmer, Kristine E., et al.
Publicado: (2022)

Preoperative CA125 Significantly Improves Risk Stratification in High-Grade Endometrial Cancer
por: Lombaers, Marike S., et al.
Publicado: (2023)

Molecular Classification of Endometrial Cancer and the 2023 FIGO Staging: Exploring the Challenges and Opportunities for Pathologists
por: Zheng, Wenxin
Publicado: (2023)

Does the use of the 2009 FIGO classification of endometrial cancer impact on indications of the sentinel node biopsy?
por: Ballester, Marcos, et al.
Publicado: (2010)

The FIGO Ovulatory Disorders Classification System
por: Munro, Malcolm G, et al.
Publicado: (2022)

The FIGO ovulatory disorders classification system
por: Munro, Malcolm G., et al.
Publicado: (2022)

High visceral fat percentage is associated with poor outcome in endometrial cancer
por: Mauland, Karen Klepsland, et al.
Publicado: (2017)

Survival analysis of revised 2013 FIGO staging classification of epithelial ovarian cancer and comparison with previous FIGO staging classification
por: Paik, E Sun, et al.
Publicado: (2015)

External validation study of endometrial cancer preoperative risk stratification model (ENDORISK)
por: Vinklerová, Petra, et al.
Publicado: (2022)

Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study
por: Reijnen, Casper, et al.
Publicado: (2020)

Relevance of Molecular Profiling in Patients With Low-Grade Endometrial Cancer
por: Vrede, Stephanie W., et al.
Publicado: (2022)

Adjuvant brachytherapy for FIGO stage I serous or clear cell endometrial cancer
por: Jeans, Elizabeth B, et al.
Publicado: (2021)

Stathmin Protein Level, a Potential Predictive Marker for Taxane Treatment Response in Endometrial Cancer
por: Werner, Henrica M. J., et al.
Publicado: (2014)

Androgen receptor as potential therapeutic target in metastatic endometrial cancer
por: Tangen, Ingvild Løberg, et al.
Publicado: (2016)

Patient-Derived Xenograft Models for Endometrial Cancer Research
por: Moiola, Cristian P., et al.
Publicado: (2018)

The impact of adipose tissue distribution on endometrial cancer: a systematic review
por: van den Bosch, Anouk A. S., et al.
Publicado: (2023)

Switch in FOXA1 Status Associates with Endometrial Cancer Progression
por: Tangen, Ingvild Løberg, et al.
Publicado: (2014)

The percentage of peripheral eosinophils as a sensitive marker for differentiating FIGO grade in endometrial adenocarcinomas
por: Akış, Serkan, et al.
Publicado: (2022)

L1CAM as a prognostic marker in stage I endometrial cancer: a validation study
por: Smogeli, Elisabeth, et al.
Publicado: (2016)

Development of prediction models for lymph node metastasis in endometrioid endometrial carcinoma
por: Berg, Hege F., et al.
Publicado: (2020)

A Risk Stratification for Patients with Cervical Cancer in Stage IIIC1 of the 2018 FIGO Staging System
por: Liu, Xiaoliang, et al.
Publicado: (2020)

Endometrial Stromal Sarcomas: A Revision of Their Potential as Targets for Immunotherapy
por: Tuyaerts, Sandra, et al.
Publicado: (2018)

Fertility-sparing treatment in early endometrial cancer: current state and future strategies
por: Obermair, Andreas, et al.
Publicado: (2020)

Impact of the adjuvant management and risk factors on survival in FIGO stage 3 endometrial cancer patients
por: Tong, Nora, et al.
Publicado: (2023)

High-Throughput Mutation Profiling of Primary and Metastatic Endometrial Cancers Identifies KRAS, FGFR2 and PIK3CA to Be Frequently Mutated
por: Krakstad, Camilla, et al.
Publicado: (2012)

Risk stratification of abdominopelvic failure for FIGO stage III epithelial ovarian cancer patients: implications for adjuvant radiotherapy
por: Chang, Jee Suk, et al.
Publicado: (2013)

FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication
por: Prat, Jaime
Publicado: (2015)

Impact of body mass index and fat distribution on sex steroid levels in endometrial carcinoma: a retrospective study
por: van Weelden, Willem Jan, et al.
Publicado: (2019)

Non-invasive detection of endometrial cancer by DNA methylation analysis in urine
por: van den Helder, Rianne, et al.
Publicado: (2020)

Proteomic profiling of endometrioid endometrial cancer reveals differential expression of hormone receptors and MAPK signaling proteins in obese versus non-obese patients
por: Mauland, Karen Klepsland, et al.
Publicado: (2017)

Outcomes of “sandwich” chemoradiotherapy compared with chemotherapy alone for the adjuvant treatment of FIGO stage III endometrial cancer
por: Wang, Shao-Jing, et al.
Publicado: (2022)

Impact of the new FIGO 2013 classification on prognosis of stage I epithelial ovarian cancers
por: Sartorius, Céline Montavon, et al.
Publicado: (2018)

Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival
por: Mauland, Karen Klepsland, et al.
Publicado: (2016)

Should the Number of Metastatic Pelvic Lymph Nodes Be Integrated into the 2018 Figo Staging Classification of Early Stage Cervical Cancer?
por: Pedone Anchora, Luigi, et al.
Publicado: (2020)

Identification of highly connected and differentially expressed gene subnetworks in metastasizing endometrial cancer
por: Kusonmano, Kanthida, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_a1u8s9ief256p0hnrhgo06jorr